Filter
536
Text search:
nucleic
Acid
Featured
Recommendations
90
New Publications
132
Language
Document type
No document type
249
Guidelines
142
Studies & Reports
69
Manuals
44
Fact sheets
14
Training Material
5
Strategic & Response Plan
5
Situation Updates
4
Infographics
2
Resource Platforms
1
Videos
1
Countries / Regions
India
31
Global
20
Western and Central Europe
17
Eastern Europe
11
South Africa
8
Africa
8
Tanzania
7
Latin America and the Carribbean
7
Liberia
6
Ethiopia
6
Nigeria
5
Nepal
5
Rwanda
5
Brazil
5
Myanmar / Burma
5
Namibia
4
Ukraine
4
Angola
4
East and Southern Africa
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Asia
4
Russia
4
Sierra Leone
3
Congo, Democratic Republic of
3
Germany
3
Zambia
3
Bangladesh
3
Argentina
3
Peru
3
Guinea
2
Senegal
2
Uganda
2
Philippines
2
Pakistan
2
Kenya
2
China
2
Mozambique
2
Middle East and North Africa
2
Vietnam
2
Portugal
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Cameroon
1
South Sudan
1
Afghanistan
1
Turkey
1
Syria
1
Chad
1
Cambodia
1
Indonesia
1
Colombia
1
Botswana
1
El Salvador
1
Sri Lanka
1
South–East Asia Region
1
Bhutan
1
Timor Leste/ East Timor
1
Moldova
1
Georgia
1
France
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
114
Clinical Guidelines
96
Pharmacy & Technologies
33
Key Resources
14
Women & Child Health
13
Public Health
12
Capacity Building
3
Toolboxes
TB
105
COVID-19
86
HIV
71
NTDs
42
Ebola & Marburg
23
Rapid Response
22
Zika
17
AMR
12
Refugee
11
Pharmacy
11
2.0 Rapid Response
11
Malaria
8
Polio
5
Planetary Health
4
Caregiver
3
Conflict
2
Mental Health
2
Health Financing Toolbox
2
Natural Hazards
1
Specific Hazards
1
Global Health Education
1
NCDs
1
2nd edition. The purpose of this document is to present updated standardized protocols that P. falciparum-endemic countries can use to determine the prevalence of parasites with pfhrp2/3 gene deletions causing negative HRP2 RDT results among symptomatic falciparum patients. The findings should be us
...
Clinical Pharmacology: Advances and Applications, 2025:17 29–47
The framework recommends expanded coverage of malaria diagnostic and treatment services, intensified vector control to drive down transmission, strengthened malaria surveillance, and increased transborder collaboration, especially in terms of efforts to control the sale and use of artemisinin monoth
...
Le Infezioni in Medicina, n. 1, 3-10, 2019
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This publication provides guidance for planning country-specific programming to achieve the triple elimination of mother-to-child (or vertical) transmission of HIV, syphilis and hepatitis B virus. It is based on the WHO Triple Elimination Framework, which promotes an integrated, person-centred appro
...
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages
...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
On 13 August 2024, the Africa Centres for Disease Control (Africa CDC) declared the multi-country mpox outbreak a public health emergency of continental security, with strong recommendations to improve surveillance and vaccine deployment in all AU Member States. On 14 August 2024, the WHO Director-G
...
20 YEARS OF STRATEGIC HIV AND PUBLIC HEALTH DATA . beThe completion of the 6th South African National HIV Prevalence, Incidence and Behaviour Survey (SABSSM) report, coincides with the celebration of 30 years of democracy in South Africa; and marks 20 years of conducting nationally representative ho
...
WHO consolidated guidelines on tuberculosis: Module 6: tuberculosis and comorbidities, 2nd ed
recommended
Addressing TB comorbidities and risk factors is central to the World Health Organization (WHO) End TB Strategy. These guidelines consolidate the latest WHO recommendations on TB and key comorbidities. The guidelines are a living document and will include dedicated sections for each key TB comorbidit
...
In an era of constrained resources and tightening budgets, strategic prioritization in tuberculosis (TB) programming is more critical than ever. Countries must make informed decisions to allocate limited resources effectively - maximizing impact, preventing avoidable deaths, and sustaining progress
...
Adapting HIV testing services in the context of reduced and declining funding. Presentation May 2025
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech
...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh
...
WHO has developed this manual in order to strengthen the laboratory diagnosis and virological surveillance of influenza infection.
Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r
...
